IP Library Granted Patent US 8,535,217
Granted Patent B2
US 8,535,217 · App. 11/989,256 · Granted Sep 17, 2013

Methods and systems for treatment of prolapse

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,535,217
App. No.
11/989,256
Granted
Sep 17, 2013
Kind
B2
Abstract

Described are implants, tools, and related methods, for use in pelvic surgery to treat conditions such as prolapse, including embodiments of methods that involve a tissue path above the arcus tendineus.

Claims (44)

1. A method of supporting posterior vaginal tissue, the method comprising

providing an implant comprising a tissue support portion and an extension portion extending from the tissue support portion,

creating a vaginal incision,

transvaginally contacting the support portion with posterior vaginal tissue,

transvaginally producing a tissue path using an insertion tool at a distal end of the extension portion, the path being produced between the position of the tissue support portion and a region of the arcus tendineus, wherein the region of the arcus tendineus comprises a region from 2 centimeters above the arcus tendineus to 2 centimeters below the arcus tendineus and between the ischial spine and a distance 3 centimeters anterior to the ischial spine, wherein the insertion tool comprises a longitudinally extending shaft and a curved portion at a distal end of the shaft, the curved portion comprising a radius of curvature in the range of from 0.5 to 1.5 centimeters, and

transvaginally extending the extension portion through the tissue path.

2. The method of claim 1 , comprising treating a condition selected from the group consisting of enterocele, rectocele, apical prolapse, and vault prolapse.

3. The method of claim 1 wherein the region of the arcus tendineus further includes the region between the arcus tendineus and 1 centimeter above the arcus tendineus, and between the ischial spine and a distance 1 centimeter anterior to the ischial spine.

4. A method of supporting posterior vaginal tissue, the method comprising:

providing an implant comprising a tissue support portion and an extension portion extending from the tissue support portion,

creating a vaginal incision,

transvaginally contacting the support portion with posterior vaginal tissue,

transvaginally producing a tissue path between the position of the tissue support portion and a region of the arcus tendineus, wherein the tissue path passes above the arcus tendineus to exit a pelvic region through the obturator intemus muscle, wraps around the arcus tendineus, and passes through the levator ani muscle back into the pelvic region, and

transvaginally extending the extension portion through the tissue path.

5. A method of supporting posterior vaginal tissue, the method comprising:

providing an implant comprising a tissue support portion and an extension portion extending from the tissue support portion,

creating a vaginal incision,

transvaginally contacting the support portion with posterior vaginal tissue,

transvaginally producing a tissue path between the position of the tissue support portion and a region of the arcus tendineus, wherein the tissue path passes above the arcus tendineus through the obturator intemus muscle, wraps around the arcus tendineus, passes through the levator ani muscle back into the pelvic region, continues through the buttock and through an external incision in a perirectal region, and

transvaginally extending the extension portion through the tissue path.

6. The method of claim 1

wherein the step of providing an implant comprises providing an implant assembly comprising

the implant comprising the tissue support portion, the extension portion, and a second extension portion,

the insertion tool attached at the distal end of the extension portion, the insertion tool comprising a proximal handle, and

a second insertion tool attached at a distal end of the second extension portion, the second insertion tool comprising a second longitudinally extending shaft, a handle, and a second curved portion at a distal end of the second longitudinally extending shaft, the second curved portion comprising a radius of curvature in a range of from 0.5 to 1.5 centimeters,

and wherein the step of transvaginally producing a tissue path comprises:

inserting the curved portion with attached extension portion through the vaginal incision,

manipulating the handle of the insertion tool to lead the distal end of the extension portion through a first tissue path in the region of the arcus tendineus,

inserting the second curved portion with attached second extension portion through the vaginal incision, and

manipulating the handle of the second insertion tool to lead the distal end of the second extension portion through a second tissue path in a region of a second arcus tendineus.

7. A pelvic implant assembly comprising

an implant comprising supportive portions comprising

a tissue support portion, and

elongate extension portions extending from the tissue support portion, and

an insertion tool at a distal end of at least one of the extension portions, the insertion tool comprising a longitudinally extending shaft having a longitudinal axis and a curved portion at a distal end of the shaft, the curved portion comprising a radius of curvature in the range of from 0.5 to 1.5 centimeters and being sized and shaped to be used in a transvaginal procedure to define a tissue path that exits the pelvic floor region in a region of the arcus tendineus, partially extends around an arcus tendineus, and re-enters the pelvic floor, wherein the region of the arcus tendineus comprises a region from 2 centimeters above the arcus tendineus to 2 centimeters below the arcus tendineus and between the ischial spine and a distance 3 centimeters anterior to the ischial spine.

8. The assembly of claim 7 wherein the curved portion has a length of from 3 to 5 centimeters.

9. The assembly of claim 8 wherein the curved portion is substantially a shape of a partial circle of from 90 to 270 degrees.

10. The assembly of claim 8 wherein the curved portion is substantially a shape of a partial circle of from 170 to 190 degrees.

11. The assembly of claim 7 wherein the insertion tool comprises

a handle having a longitudinal axis,

wherein the shaft has a proximal end and a distal end, the proximal end of the shaft attached at the distal end of the handle, the longitudinal axis of the shaft aligned with the longitudinal axis of the handle, and

the curved portion at the distal end of the shaft, the curved portion having a length of from 3 to 5 centimeters.

12. The assembly of claim 11 wherein the distal end of at least one of the extension portions engages a leading end of the curved portion.

13. The assembly of claim 11 wherein the tool is capable of being used to transvaginally place the curved portion in contact with tissue in a region of the arcus tendineus, and the handle can be manipulated with movement that includes rotation of the handle about a longitudinal axis through the shaft to cause the curved portion to produce a tissue path.

Assignments (17)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2013
From: COX, JAMES E.; ANDERSON, KIMBERLY A.
To: AMS RESEARCH CORPORATION
Reel/Frame 031008/0762 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →